Consumer AI Is Becoming Healthcare’s Front Door

A new Nature Health Perspective examines emerging healthcare ecosystems involving ChatGPT Health, Amazon Health AI, Anthropic’s Claude for Healthcare and Ant Group’s Afu/AQ.

Consumer AI platforms are beginning to connect symptom interpretation, medical records, care routing, appointment booking, pharmacy fulfilment, payment and clinical workflows. This integration could help patients navigate fragmented systems and complete pathways that might otherwise break down—particularly where access is already difficult.

But deeper integration also creates new forms of power. A small number of platforms may increasingly determine where patients enter healthcare, which services they encounter and how their information and transactions move across the system. Technology companies could gain unprecedented visibility into both health data and healthcare behaviour.

My takeaway: the central question is no longer only, “How accurate is the model?” It is increasingly, “Who controls the pathway?”

Once one platform can interpret symptoms, recommend where to seek care, influence which provider appears, connect the medical record, arrange an appointment, fulfil a prescription and process payment, it is no longer merely an information tool. It becomes healthcare infrastructure.

Governance must therefore extend beyond the model to the complete deployed system: AI, interface, data, routing, transactions, incentives and care pathway. This should include pathway-level accountability, routing transparency, data governance, meaningful exit options and scrutiny of the commercial incentives shaping recommendations.

Important limitation: this is a Perspective, not an empirical evaluation demonstrating improved outcomes or harm. The platforms described also differ substantially in their current capabilities and integration.